Bharat Biotech | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
June 06, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JUNE 06, 2025

Bharat Biotech

Photo: Collected
Coronavirus chronicle

India launches world’s 1st intranasal Covid vaccine

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

‘Big boost’: Bharat Biotech’s nasal Covid-19 vaccine gets green light

Indian drug regulator okays Covaxin for 6-12 year olds, Corbevax for 5-12 bracket
Coronavirus chronicle

Indian drug regulator okays Covaxin for 6-12 year olds, Corbevax for 5-12 bracket

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

India gives nod to Bharat Biotech for intranasal Covid booster doses

A woman receives a booster dose of Covaxin, a coronavirus disease (Covid-19) vaccine manufactured by Bharat Biotech, at a vaccination centre in New Delhi, India, January 10, 2022. Photo :Reuters
Coronavirus chronicle

India's Bharat Biotech says Covaxin booster shot neutralises Omicron

Rupali Deshraj Nirmal, 16, reacts as she receives a dose of Bharat Biotech's Covid-19 vaccine, Covaxin, during a vaccination drive for children aged 15-18 in Mumbai, India, January 3, 2022. Photo :Reuters
Coronavirus chronicle

Bharat Biotech gets approval to test nasal Covid-19 shot as booster - report

Photo : Deccan Herald
Coronavirus chronicle

Bharat Biotech to produce 1 billion nasal vaccines in 2022

Nuns hold an elderly man as he receives a dose of COVAXIN coronavirus disease (Covid-19) vaccine manufactured by Bharat Biotech, at a home for elderly in Mumbai, India, August, 2, 2021. Photo :Reuters
Coronavirus chronicle

Bharat's Covid-19 shot 50% effective at height of India infections - small study

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

India recommends homemade Covid-19 vaccine for kids aged 2 and above

In the case of procurement of Covaxin by Brazil, a step-by-step approach followed, Bharat Biotech said.
World+Biz

Bharat Biotech says it received no advance payment from Brazil govt for Covaxin

Bharat Biotech's clarification comes at a time when the country is facing a shortage of Covid-19 vaccines, leading to disruptions in the nationwide inoculation programme.(Bloomberg)
Coronavirus chronicle

Covaxin manufacturing to vaccination takes 4 months, says Bharat Biotech

Photo: UNB
Coronavirus chronicle

Bharat Biotech submits ‘90% of documents’ for WHO nod

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

India's Bharat Biotech to produce additional 200 mln Covid-19 vaccine doses per year

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net